Proper definitions of MRI contrast enhancement in liver tumors

Journal of Gastroenterology

Volumn 45, Issue 3, 2010, Pages 349-350

  Ni, Yicheng ^a,b   Chen, Feng ^a   Wang, Huaijun ^a   Feng, Yuanbo ^a   Li, Junjie ^a   Jiang, Yansheng ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; GADOXETIC ACID; SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY MEMBER 1B3; UNCLASSIFIED DRUG;

CANCER GRADING; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG UPTAKE; HISTOPATHOLOGY; HUMAN; LETTER; LIVER CELL CARCINOMA; LIVER TUMOR; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELIABILITY; TISSUE SPECIFICITY; TUMOR DIFFERENTIATION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; RATS;

EID: 77950461558     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-009-0174-z     Document Type: Letter

References (12)

1. Narita M, Hatano E, Arizono S, Miyagawa-Hayashino A, Isoda H, Kitamura K, et al. Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol. 2009;44(7):793-798
2. Weinmann H-J, Schuhmann-Giampieri G, Schmitt-Willich H, Vogler H, Frenzel T, Gries H. A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI. Magn Reson Med. 1991;22:233-237
3. Ni Y, Marchal G, Yu J, Mühler A, Lukito G, Baert AL. Prolonged positive enhancement by Gd-EOB-DTPA in experimental liver tumors: potential value in tissue characterization. J Magn Reson Imaging. 1994;4:355-363
4. Ni Y, Marchal G. Enhanced magnetic resonance imaging for tissue characterization of liver abnormalities with hepatobiliary contrast agents: an overview of preclinical animal experiments. Top Magn Reson Imaging. 1998;9(3):183-195 (Pubitemid 28268207)
5. Vogl TJ, Kümmel S, Hammerstingl R, Schellenbeck M, Schumacher G, Balzer T, et al. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology. 1996; 200:59-67. (Pubitemid 26197732)
6. Reimer P, Rummeny EJ, Daldrup HE, Hesse T, Balzer T, Tom-bach B, et al. Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging. Eur Radiol. 1997;7:275-280 (Pubitemid 127538595)
7. Huppertz A, Haraida S, Kraus A, Zech CJ, Scheidler J, Breuer J, et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT-initial observations. Radiology. 2005;234:468-478 (Pubitemid 40139918)
8. Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol. 2008;43:504-511
9. Ni Y, Wang H, Chen F, Li J, Feng Y, DeKeyzer F, et al. Tumor models and specific contrast agents for small animal imaging in oncology. Methods. 2009;48:125-138
10. Fujita M, Yamamoto R, Takahashi M, Tsuji T, Yamanaka T, Miyazawa T, et al. Paradoxic uptake of Gd-EOB-DTPA by hepatocellular carcinoma in mice: quantitative image analysis. J Magn Reson Imaging. 1997;7:768-770 (Pubitemid 28365630)
11. Tsuda N, Kato N, Murayama C, Narazaki M, Yokawa T. Potential for differential diagnosis with gadolinium-ethoxyben-zyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in experimental hepatic tumors. Invest Radiol. 2004;39:80-88
12. Fujita M, Yamamoto R, Fritz-Zieroth B, Yamanaka T, Takahashi M, Miyazawa T, et al. Contrast enhancement with Gd-EOB-DTPA in MR imaging of hepatocellular carcinoma in mice: a comparison with superparamagnetic iron oxide. J Magn Reson Imaging. 1996;6(3):472-477